# Study of the Safety and Tolerability of IV Infused PG545 in Patients With Advanced Solid Tumours

> **NCT02042781** · PHASE1 · COMPLETED · sponsor: **Zucero Pty Ltd** · enrollment: 23 (actual)

## Conditions studied

- Advanced Solid Tumours

## Interventions

- **DRUG:** PG545

## Key facts

- **NCT ID:** NCT02042781
- **Lead sponsor:** Zucero Pty Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-01
- **Primary completion:** 2016-06
- **Final completion:** 2016-09
- **Target enrollment:** 23 (ACTUAL)
- **Last updated:** 2017-10-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02042781

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02042781, "Study of the Safety and Tolerability of IV Infused PG545 in Patients With Advanced Solid Tumours". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT02042781. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*